Revolutionary Blood Microsampling Assay by Cellecta, Inc.
Introduction to Cellecta's Innovative Blood Testing
Cellecta, Inc. has unveiled a groundbreaking approach to gene expression analysis that opens new doors to medical research. This advancement is made possible by the introduction of the DriverMap™ EXP Human Genome-Wide Profiling kit, which requires only a minuscule amount of blood for thorough testing. Imagine being able to gather significant biological data from just one drop of dried blood!
The Science Behind the DriverMap™ EXP Kit
This innovative assay combines the simplicity of blood collection with powerful molecular profiling technology. By using a finger-prick blood collection method, researchers can now collect samples comfortably at home. What makes this method incredibly powerful is its ability to assess 19,000 human protein-coding genes from merely 30 microliters of dried blood.
Understanding RNA Stability Challenges
Transcribing gene expression has often been a challenge due to the instability of RNA in regular blood samples. However, Cellecta’s advanced technology overcomes these hurdles efficiently. The DriverMap EXP utilizes Trajan Scientific and Medical's Neoteryx microsampling tools. These tools are designed to safely stabilize RNA, allowing them to maintain integrity even after being stored for extended periods.
Convenience and Efficiency: A New Era for Researchers
This assay significantly simplifies the experimental workflow. Researchers can now enjoy a smooth, single-day process that involves:
- Collection of blood via a fingertip samply using lancet puncture, absorbed into VAMS sampling tips for RNA stabilization.
- Extraction of RNA from VAMS tips using a specialized buffer solution that is part of the DriverMap EXP Dried Blood kit.
- Data processing which results in actionable insights regarding gene expression.
Transforming Research Applications
Dr. Alex Chenchik, Cellecta's president and chief scientific officer, emphasized the assay's potential, stating that the use of dried blood microsamples yields results comparable to standard blood volumes. This breakthrough enables researchers to conduct multi-sample studies or longitudinal analyses crucial for identifying biomarkers for various diseases.
Product Availability and Applications
The DriverMap™ EXP Dried Blood Microsample Profiling kit is available in configurations supporting 24 or 96 samples. This flexibility makes it highly accessible for various research applications, streamlining the process of biomarker discovery, which can ultimately aid in the diagnosis and prognostication of numerous health conditions.
About Cellecta, Inc.
Cellecta, Inc. stands as a reputable partner in the realm of genomic product offerings and services. With a history that dates back to 2006, they have built trust with leading organizations in pharmaceutical, biotech, and academic fields, helping unlock numerous genetic secrets that facilitate drug discovery and biomarker validation.
Frequently Asked Questions
What is the DriverMap™ EXP Profiling kit?
The DriverMap™ EXP kit is a blood microsampling assay that profiles 19,000 human protein-coding genes from as little as 30 microliters of dried blood.
How does it improve on traditional RNA profiling methods?
By utilizing dried blood samples which are stabilized, it overcomes the instability issues associated with conventional blood sample collection, providing more reliable gene expression data.
What is the significance of the 30 microliters requirement?
This small volume makes blood sampling less invasive and more convenient, expanding accessibility for large-scale studies.
Who can benefit from using the DriverMap assay?
Researchers across pharmaceutical, biotech, and academic fields can utilize this technology for various applications, including biomarker discovery and validation studies.
Where can I buy the DriverMap™ EXP kit?
The DriverMap kit is available for purchase from Cellecta Inc., offering two configurations for a total of 24 or 96 samples.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
